In my August 10, 2021 Viatris (VTRS) stock analysis I reviewed Q2 and YTD financial results and the company's valuation based on guidance. I now revisit VTRS following the November 8, 2021 release of Q3 and YTD 2021 results and revised FY2021 guidance. Viatris - Stock Analysis - Business Overview VTRS's FY2020 Form 10-K provides [...]
In my September 3, 2021 post I disclose the purchase of additional Mastercard Incorporated (MA) shares @ $340.3929/share in one of the 'Core' accounts in the FFJ Portfolio. On October 26, Visa (V) released Q4 and FY2021 results. The share price of both V and MA plunged so I acquired more shares in both companies [...]
In my February 8, 2021 Merck & Co., Inc. (MRK) stock analysis I disclosed that my findings led me to initiate a 300 share position in one of the 'Core' accounts in the FFJ Portfolio. I subsequently analyzed Q1 2021 results and FY2021 guidance in my May 3, 2021 MRK stock analysis and disclosed the [...]
Previous Exxon Mobil (XOM) posts are accessible in the FFJ Archives. In my previous XOM stock analysis, I concluded shares were attractively valued and acquired another 200 shares in a 'Core' account in the FFJ Portfolio. At the time of that post, XOM's share price was ~$57. The share price is now ~$64.50 and with [...]
Previous Chevron Corporation (CVX) posts are accessible in the FFJ Archives. In my most recent post, I concluded CVX shares were attractively valued and acquired additional shares in a 'Core' account in the FFJ Portfolio. At the time of that post, CVX's share price was ~$99. The share price is now ~$114.50 and with the [...]
This Cboe Global Markets, Inc. (CBOE) stock analysis is the 9th in my series of analyses of Financial Data & Stock Exchanges industry participants. Previous posts within this series are accessible here. I view the Financial Data & Stock Exchanges industry as an attractive industry in which to invest for the long term. I currently [...]
In anticipation of strong Q3 and YTD2021 results, I initiated a 200 shares Abbvie Inc. (ABBV) position @ $108.70/share on October 22, 2021 in one of the 'Core' accounts in the FFJ Portfolio. With the release of Q3 and YTD2021 results on October 29, I now provide this ABBV stock analysis. Abbvie - Stock Analysis [...]
This is my FFJ Portfolio - October 2021 Report. In October, I undertook an analysis of Financial Data & Stock Exchanges industry participants. My posts are accessible through the Archives. In addition, I wrote a guest post about Cisco (CSCO) at Dividend Power. FFJ Portfolio Holdings Monthly FFJ Portfolio holdings reports from December 2018 to [...]
In my September 3, 2021 post, I disclose the purchase of additional Visa Inc. (V) shares in one of the 'Core' accounts in the FFJ Portfolio. Just before the release of Q4 and FY2021 results, V was trading at ~$234. V's share price is currently ~$212. After reviewing V's results and FY2022 outlook I have [...]
This Moody's Corporation (MCO) stock analysis is the 8th in my series of analyses of Financial Data & Stock Exchanges industry participants. Previous posts within this series are accessible here. I view the Financial Data & Stock Exchanges industry as an attractive industry in which to invest for the long term and currently have exposure [...]
